Education
About Us
Working with TipRanks
Follow Us
Kairos Pharma, Ltd. (KAPA)
:KAPA
Kairos Pharma, Ltd. (KAPA) Ownership Overview
32.20% Insiders
0.14% Mutual Funds
0.40% Other Institutional Investors
0.33% ETFs
66.93% Public Companies and
Individual Investors
The ownership structure of Kairos Pharma, Ltd. (KAPA) stock is a mix of institutional, retail, and individual investors. Approximately 0.87% of the company’s stock is owned by Institutional Investors, 32.20% is owned by Insiders, and 66.93% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,355,838 | Insider | 25.72% | 3,824,068 | |
| 1,139,983 | Insider | 5.48% | 813,948 | |
| 147,057 | Insider | 0.71% | 104,999 | |
| 67,944 | Institution | 0.33% | 48,512 | |
| 60,796 | Insider | 0.29% | 43,408 | |
| 29,976 | Institution | 0.14% | 21,403 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 29,976 | Institution | 0.14% | 21,403 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 67,944 | Institution | 0.33% | 76,777 |
FAQ
Who Owns Kairos Pharma, Ltd. (KAPA)?
According to the latest TipRanks data, approximately 0.40% of the company's stock is held by institutional investors, 32.20% is held by insiders, and 66.93% is held by retail investors.
What percentage of Kairos Pharma, Ltd. (KAPA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.40% of Kairos Pharma, Ltd. (KAPA) stock is held by institutional investors.
What percentage of Kairos Pharma, Ltd. (KAPA) stock is held by retail investors?
According to the latest TipRanks data, approximately 66.93% of Kairos Pharma, Ltd. (KAPA) stock is held by retail investors.
Who owns the most shares of Kairos Pharma, Ltd. (KAPA)?
John S Yu owns the most shares of Kairos Pharma, Ltd. (KAPA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.